Plain-English translation of NCT05650411 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new approach to blood thinner medication after heart stent placement. You would receive a special ultrathin stent (called Supraflex Cruz) to open a blocked main coronary artery, and then take blood thinners for a shorter period than the standard approach. The study wants to see if this shorter course is as safe and effective as the traditional longer treatment plan.
After a heart stent is placed, patients typically need to take multiple blood thinners together for 6–12 months to prevent dangerous blood clots. This trial is testing whether a shorter course of these medications followed by a single blood thinner might work just as well, while reducing your medication burden and potential side effects.
You likely qualify if…
You likely don't qualify if…
You will receive a stent procedure to open your blocked main heart artery. After the procedure, you will be assigned to one of two groups: one group will take blood thinners for a shorter time (stopping one medication early after 2 months), while the other group will follow the standard approach of taking two blood thinners together for 6–12 months. You will attend follow-up visits over the course of the study to check your health and make sure the treatment is working well.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
Switzerland